Literature DB >> 19242111

Total ERK1/2 activity regulates cell proliferation.

Renaud Lefloch1, Jacques Pouysségur, Philippe Lenormand.   

Abstract

Regulating ERK activity is essential for normal cell proliferation to occur. In mammals and most vertebrates ERK activity is provided by ERK1 and ERK2 that are highly similar, ubiquitously expressed and share activators and substrates. By combining single and double silencings of ERK1 and ERK2 we recently demonstrated that the apparent dominant role of ERK2 to regulate cell proliferation was due to its markedly higher expression level than ERK1. The contribution of ERK1 was revealed when ERK2 activation was clamped to avoid compensating over-activation of ERK2. We found no evidences in the literature for insulated isoform-specific modules in the Ras/Raf/MEK signaling cascade that could activate specifically ERK1 or ERK2. Obviously in frogs all signal integration and fine modulation provided by three Ras and three Raf isoforms is conducted by only one MEK and one ERK isoform. In mammals, ERK1 and ERK2 display similar specific activities and are activated respectively to their expression levels. After integrating signals from Ras, Raf and MEK isoforms, ERK1 and ERK2 regulate positively cell proliferation according to their expression levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242111     DOI: 10.4161/cc.8.5.7734

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  43 in total

1.  Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.

Authors:  Carmela Ciccarelli; Agnese Di Rocco; Giovanni Luca Gravina; Annunziata Mauro; Claudio Festuccia; Andrea Del Fattore; Paolo Berardinelli; Francesca De Felice; Daniela Musio; Marina Bouché; Vincenzo Tombolini; Bianca Maria Zani; Francesco Marampon
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-29       Impact factor: 4.553

2.  The ERK/CREB pathway is involved in the c-Ski expression induced by low TGF-β1 concentrations during primary fibroblast proliferation.

Authors:  Ping Li; Ping Liu; Yan Peng; Zhuo-Hang Zhang; Xiao-Ming Li; Ren-Ping Xiong; Xing Chen; Yan Zhao; Ya-Lei Ning; Nan Yang; Bo Zhang; Yuan-Guo Zhou
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

Review 3.  Robustness of signal transduction pathways.

Authors:  Nils Blüthgen; Stefan Legewie
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

Review 4.  The role of epithelial growth factors and insulin growth factors in the adrenal neoplasms.

Authors:  Anna Angelousi; Georgios Kyriakopoulos; Narjes Nasiri-Ansari; Margarita Karageorgou; Eva Kassi
Journal:  Ann Transl Med       Date:  2018-06

5.  Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation.

Authors:  Laure Voisin; Marc K Saba-El-Leil; Catherine Julien; Christophe Frémin; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

Review 6.  The Regulatory Roles of Mitogen-Activated Protein Kinase (MAPK) Pathways in Health and Diabetes: Lessons Learned from the Pancreatic β-Cell.

Authors:  Vaibhav Sidarala; Anjaneyulu Kowluru
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2017

7.  Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults.

Authors:  Kwangsik Nho; Vijay K Ramanan; Emrin Horgusluoglu; Sungeun Kim; Mark H Inlow; Shannon L Risacher; Brenna C McDonald; Martin R Farlow; Tatiana M Foroud; Sujuan Gao; Christopher M Callahan; Hugh C Hendrie; Alexander B Niculescu; Andrew J Saykin
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity.

Authors:  Cornelia Tolg; Sara R Hamilton; Lyndsey Morningstar; Jing Zhang; S Zhang; Kenneth V Esguerra; Patrick G Telmer; Len G Luyt; Rene Harrison; James B McCarthy; Eva A Turley
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

9.  Combination of ERK2 and STAT3 Inhibitors Promotes Anticancer Effects on Acute Lymphoblastic Leukemia Cells.

Authors:  Ewa Jasek-Gajda; Halina Jurkowska; MaŁgorzata JasiŃska; Jan A Litwin; Grzegorz J Lis
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

10.  Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling.

Authors:  P V Spirin; T D Lebedev; N N Orlova; A S Gornostaeva; M M Prokofjeva; N A Nikitenko; S E Dmitriev; A A Buzdin; N M Borisov; A M Aliper; A V Garazha; P M Rubtsov; C Stocking; V S Prassolov
Journal:  Leukemia       Date:  2014-04-14       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.